AltheaDx, Inc. - Product Pipeline Analysis, 2014 Update

Date: July 15, 2014
Pages: 18
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A823E29B63FEN
Leaflet:

Download PDF Leaflet

AltheaDx, Inc. - Product Pipeline Analysis, 2014 Update
Summary

AltheaDx, Inc. (AltheaDx) is a biotechnology company. The company provides molecular biomarker discovery, assay development, assay validation and prospective and retrospective clinical trial testing services. Its discovery services include microarray analysis, real-time PCR, next-gen sequencing, quantitative PCR, mutation scanning, data analysis, and therapeutic siRNA. AltheaDx provides clinical trial services, such as predictive drug response, patient stratification, efficacy monitoring, disease staging, and vaccine and gene therapy. The company partners with Beckman Coulter, Nicholas Conor Institute and Compendia Bioscience. AltheaDx is headquartered in San Diego, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company AltheaDx, Inc.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
AltheaDx, Inc. Company Snapshot
AltheaDx, Inc. Company Overview
Key Information
AltheaDx, Inc. Pipeline Products and Clinical Trials Overview
AltheaDx, Inc. – Pipeline Analysis Overview
Key Facts
AltheaDx, Inc. - Major Products and Services
AltheaDx, Inc. Pipeline Products by Development Stage
AltheaDx, Inc. Pipeline Products Overview
OncoScore - Lung Cancer Segregation Panel
OncoScore - Lung Cancer Segregation Panel Product Overview
OncoScore - Ovarian Cancer Segregation Panel
OncoScore - Ovarian Cancer Segregation Panel Product Overview
Prognostic Assay - Prostate Cancer
Prognostic Assay - Prostate Cancer Product Overview
AltheaDx, Inc. - Key Competitors
AltheaDx, Inc. - Key Employees
AltheaDx, Inc. - Locations And Subsidiaries
Head Office
Recent Developments
AltheaDx, Inc., Recent Developments
Jun 27, 2011: AltheaDx Launches Next-Generation Sequencing Services Into Clinical Molecular Pathology
Apr 28, 2010: AltheaDx Appoints Ann Kessler To Board
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

AltheaDx, Inc., Key Facts
AltheaDx, Inc. Pipeline Products and Clinical Trials Overview
AltheaDx, Inc. Pipeline Products by Equipment Type
AltheaDx, Inc. Pipeline Products by Indication
AltheaDx, Inc., Key Facts
AltheaDx, Inc., Major Products and Services
AltheaDx, Inc. Number of Pipeline Products by Development Stage
AltheaDx, Inc. Pipeline Products Summary by Development Stage
OncoScore - Lung Cancer Segregation Panel - Product Status
OncoScore - Lung Cancer Segregation Panel - Product Description
OncoScore - Ovarian Cancer Segregation Panel - Product Status
OncoScore - Ovarian Cancer Segregation Panel - Product Description
Prognostic Assay - Prostate Cancer - Product Status
Prognostic Assay - Prostate Cancer - Product Description
AltheaDx, Inc., Key Employees

LIST OF FIGURES

AltheaDx, Inc. Pipeline Products by Equipment Type
AltheaDx, Inc. Pipeline Products by Development Stage
Skip to top


Ask Your Question

AltheaDx, Inc. - Product Pipeline Analysis, 2014 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: